Hongwei Huang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hongwei Huang

Showing results (211-220 of 216) with videos related to

Pageof 22

Sort By:

You have reached the last page of results.This site can display upto 216 results.

Antiviral Research|March 5, 2023

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccineChangrui Lu, Yuntao Zhang, Xiaohu Liu, et al.

BJS Open|November 5, 2025

Risk factors for hepatocellular carcinoma rupture: multicentre retrospective studyFeng Xia, Yiyang Liu, Hongwei Huang, et al.

Journal of Medicinal Chemistry|November 24, 2025

Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.

National Science Review|October 25, 2021

eGPS 1.0: comprehensive software for multi-omic and evolutionary analysesDalang Yu, Lili Dong, Fangqi Yan, et al.

RSC Medicinal Chemistry|August 18, 2025

Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degraderDouglas L Orsi, Kiel E Lazarski, Reina Improgo, et al.

Gut|September 29, 2025

Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studiesYinan Shen, Xinyan Jin, Wei Song, et al.

Pageof 22

Search research articles

Showing results (211-220 of 216) with videos related to

Sort By:

Pageof 22

You have reached the last page of results.This site can display upto 216 results.

Antiviral Research|March 5, 2023

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccineChangrui Lu, Yuntao Zhang, Xiaohu Liu, et al.

BJS Open|November 5, 2025

Risk factors for hepatocellular carcinoma rupture: multicentre retrospective studyFeng Xia, Yiyang Liu, Hongwei Huang, et al.

Journal of Medicinal Chemistry|November 24, 2025

Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.

National Science Review|October 25, 2021

eGPS 1.0: comprehensive software for multi-omic and evolutionary analysesDalang Yu, Lili Dong, Fangqi Yan, et al.

RSC Medicinal Chemistry|August 18, 2025

Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degraderDouglas L Orsi, Kiel E Lazarski, Reina Improgo, et al.

Gut|September 29, 2025

Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studiesYinan Shen, Xinyan Jin, Wei Song, et al.

Pageof 22